The role of bariatric surgery in the treatment of type 2 diabetes mellitus

Journal of the Royal College of Physicians of Edinburgh

Volumn 42, Issue 3, 2012, Pages 194-198

  Leong, W B ^a   Taheri, S ^b  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Bariatric surgery; Diabetes remission; Obesity; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BLOOD PRESSURE REGULATION; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; COMPARATIVE EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; EDITORIAL; GASTRIC BANDING; GASTROPLASTY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIFESTYLE MODIFICATION; LONG TERM CARE; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT SAFETY; PATIENT SELECTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; RISK REDUCTION; SLEEVE GASTRECTOMY; STOMACH BYPASS; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW (TOPIC); TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

BARIATRIC SURGERY; BODY MASS INDEX; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; HUMANS; OBESITY; WEIGHT LOSS;

EID: 84872180442     PISSN: 14782715     EISSN: None     Source Type: Journal    
DOI: 10.4997/JRCPE.2012.301     Document Type: Editorial

References (43)

1. The NHS Information Centre. Health and lifestyles: summary of key findings [Internet]. London: The Health and Social Care Information Centre; 2010 [cited 2012 June 14]. Available from: http://www. ic.nhs.uk/webfiles/publications/003_Health_Lifestyles/hse09report/ HSE_09_Summary.pdf
2. Wang YC, McPherson K, Marsh T et al. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 2011; 378:815-25. http://dx.doi.org/10.1016/S0140-6736(11)60814-3
3. Diabetes UK. Diabetes in the UK 2011/2012: key statistics on diabetes [Internet]. London: Diabetes UK; 2011 [cited 2012 May 25]. Available from: http://www.diabetes.org.uk/documents/ reports/diabetes-in-the-uk-2011-12.pdf
4. Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Int Med 2010; 170:1566-75. http://dx.doi.org/10.1001/archinternmed.2010.334
5. Dixon JB, O'Brien PE, Playfair J et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008; 299:316-23. http://dx.doi.org/10.1001/jama.299.3.316
6. Wadden TA, Volger S, Sarwer DB et al. A two-year randomized trial of obesity treatment in primary care practice. N Engl J Med 2011; 365:1969-79. http://dx.doi.org/10.1056/NEJMoa1109220
7. Flum DR, Belle SH, King WC et al. Perioperative safety in the longitudinal assessment of bariatric surgery. New Engl J Med 2009; 361:445-54. http://dx.doi.org/10.1056/NEJMoa0901836
8. Dixon JB, Zimmet P, Alberti KG et al. Bariatric surgery: an IDF statement for obese type 2 diabetes. Surg Obes 2011; 7:433-47. http://dx.doi.org/10.1016/j.soard.2011.05.013
9. National Institute for Health and Clinical Excellence. Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children [Internet]. London: NICE; 2006 [cited 2012 Jun 14]. Available from: http://www.nice.org.uk/ nicemedia/pdf/CG43NICEGuideline.pdf
10. Scottish Intercollegiate Guidelines Network. Management of obesity: a national clinical guideline [Internet]. Edinburgh: SIGN; 2010 [cited 2012 May 25]. Available from: http://www.sign.ac.uk/ guidelines/fulltext/115/index.html
11. Date Y, Kojima M, Hosoda H et al. Ghrelin, a novel growth hormonereleasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000; 141:4255-61. http://dx.doi.org/10.1210/en.141.11.4255
12. De Silva A, Bloom SR. Gut hormones and appetite control: a focus on PYY and GLP-1 as therapeutic targets in obesity. Gut Liver 2012; 6:10-20. http://dx.doi.org/10.5009/gnl.2012.6.1.10
13. Arita Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Comm 1999; 257:79-83. http://dx.doi.org/10.1006/bbrc.1999.0255
14. Weyer C, Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86:1930-5. http://dx.doi.org/10.1210/jc.86.5.1930
15. Butner KL, Nickols-Richardson SM, Clark SF et al. A review of weight loss following Roux-en-Y gastric bypass vs restrictive bariatric surgery: impact on adiponectin and insulin. Obes Surg 2010; 20:559-68. http://dx.doi.org/10.1007/s11695-010-0089-z
16. Sjostrom L, Lindroos AK, Peltonen M et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351:2683-93. http://dx.doi.org/10.1056/ NEJMoa035622
17. Barr EL, Zimmet PZ, Welborn TA et al. Risk of cardiovascular and allcause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 2007; 116:151-7. http://dx.doi.org/10.1161/CIRCULATIONAHA.106.685628
18. Buse JB, Caprio S, Cefalu WT et al. How do we define cure of diabetes? Diabetes Care 2009; 32:2133-5. http://dx.doi.org/10.2337/ dc09-9036
19. Buchwald H, Estok R, Fahrbach K et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122:248-56 e5.
20. Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292:1724-37. http://dx.doi.org/10.1001/jama.292.14.1724
21. Dixon JB, Murphy DK, Segel JE et al. Impact of laparoscopic adjustable gastric banding on type 2 diabetes. Obes Rev 2012; 13:57-67. http://dx.doi.org/10.1111/j.1467-789X.2011.00928.x
22. Mingrone G, Panunzi S, De Gaetano A et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. New Engl J Med 2012; 366:1577-85. http://dx.doi.org/10.1056/NEJMoa1200111
23. Lee WJ, Chong K, Ser KH et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg 2011; 146:143-8. http://dx.doi.org/10.1001/ archsurg.2010.326
24. Pournaras DJ, Aasheim ET, Sovik TT et al. Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Surg 2012; 99:100-3. http://dx.doi. org/10.1002/bjs.7704
25. Heneghan HM, Meron-Eldar S, Brethauer SA et al. Effect of bariatric surgery on cardiovascular risk profile. Am J Cardiol 2011; 108:1499-507.
26. Sarkhosh K, Birch DW, Shi X et al. The impact of sleeve gastrectomy on hypertension: a systematic review. Obes Surg 2012; 22:832-7. http://dx.doi.org/10.1007/s11695-012-0615-2
27. Dixon JB, O'Brien PE. Lipid profile in the severely obese: changes with weight loss after lap-band surgery. Obes Res 2002; 10:903-10. http://dx.doi.org/10.1038/oby.2002.124
28. Zhang F, Strain GW, Lei W. Changes in lipid profiles in morbidly obese patients after laparoscopic sleeve gastrectomy (LSG). Obes Surg 2011; 21:305-9. http://dx.doi.org/10.1007/s11695-010-0285-x
29. Sovik TT, Aasheim ET, Taha O et al. Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial. Ann Intern Med 2011; 155:281-91.
30. O'Brien PE, Dixon JB, Laurie C et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med 2006; 144:625-33.
31. Dymek MP, Le Grange D, Neven K et al. Quality of life after gastric bypass surgery: a cross-sectional study. Obes Res 2002; 10:1135-42. http://dx.doi.org/10.1038/oby.2002.154
32. Boan J, Kolotkin RL, Westman EC et al. Binge eating, quality of life and physical activity improve after Roux-en-Y gastric bypass for morbid obesity. Obes Surg 2004; 14:341-8. http://dx.doi. org/10.1381/096089204322917864
33. Kitzinger HB, Abayev S, Pittermann A et al. After massive weight loss: patients' expectations of body contouring surgery. Obes Surg 2012; 22:544-8. http://dx.doi.org/10.1007/s11695-011-0551-6
34. Steiner CA, Bass EB, Talamini MA et al. Surgical rates and operative mortality for open and laparoscopic cholecystectomy in Maryland. New Engl J Med 1994; 330:403-8. http://dx.doi.org/10.1056/ NEJM199402103300607
35. Buchwald H, Estok R, Fahrbach K et al. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery 2007; 142:621-32; discussion 32-5. http://dx.doi.org/10.1016/j. surg.2007.07.018
36. Pajecki D, Dalcanalle L, Souza de Oliveira CP et al. Follow-up of Roux-en-Y gastric bypass patients at 5 or more years postoperatively. Obes Surg 2007; 17:601-7. http://dx.doi. org/10.1007/s11695-007-9104-4
37. Fujioka K, DiBaise JK, Martindale RG. Nutrition and metabolic complications after bariatric surgery and their treatment. JPEN J Parenter Enteral Nutr 2011; 35:52S-9S. http://dx.doi. org/10.1177/0148607111413600
38. Saif T, Strain GW, Dakin G et al. Evaluation of nutrient status after laparoscopic sleeve gastrectomy 1, 3, and 5 years after surgery. Surgery Obes Relat Dis. Epub 2012 Feb 1. http://dx.doi.org/10.1016/j. soard.2012.01.013
39. Damms-Machado A, Friedrich A, Kramer KM et al. Pre-and postoperative nutritional deficiencies in obese patients undergoing laparoscopic sleeve gastrectomy. Obes Surg 2012; 22:881-9. http:// dx.doi.org/10.1007/s11695-012-0609-0
40. Singhal R, Super P. Gastric banding-to band or bypass. The case for laparoscopic banding. Ann R Coll Surg Engl 2008; 90:4-6.
41. Wool D, Bellatorre N, Wren S et al. Male patients above age 60 have as good outcomes as male patients 50-59 years old at 1-year follow-up after bariatric surgery. Obes Surg 2009; 19:18-21. http:// dx.doi.org/10.1007/s11695-008-9734-1
42. Sosa JL, Pombo H, Pallavicini H et al. Laparoscopic gastric bypass beyond age 60. Obes Surg 2004; 14:1398-401. http://dx.doi. org/10.1381/0960892042583833
43. Picot J, Jones J, Colquitt JL et al. The clinical effectiveness and costeffectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess 2009; 13:1-190, 215-357, iii-iv.